Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan;13(1):31-9.
doi: 10.1513/AnnalsATS.201412-572OC.

Health-related Quality of Life and Survival in Pulmonary Arterial Hypertension

Stephen C Mathai  1 , Tomeka Suber  2 , Rubina M Khair  1 , Todd M Kolb  1 , Rachel L Damico  1 , Paul M Hassoun  1
Affiliations

Health-related Quality of Life and Survival in Pulmonary Arterial Hypertension

Stephen C Mathai et al. Ann Am Thorac Soc. 2016 Jan.

Abstract

Rationale: Pulmonary arterial hypertension is a progressive disease with high morbidity and mortality despite advances in medical therapy. The relationship between patient-related outcomes, such as health-related quality of life (HRQOL), and survival is not well described.

Objective: To assess the relationship between HRQOL and outcomes in patients with pulmonary arterial hypertension.

Methods: Consecutive patients with right heart catheterization-proven pulmonary arterial hypertension who completed the Medical Outcomes Survey Short Form-36 survey (SF-36) were included. Demographic, clinical, physiological, and hemodynamic data were collected at baseline. Survival was assessed from the time of diagnosis of pulmonary arterial hypertension. Cox proportional hazard models were constructed to assess the relationship between HRQOL and transplant-free survival.

Measurements and main results: Eighty-seven patients with pulmonary arterial hypertension were enrolled and followed prospectively for a median of 3.8 years. At baseline, HRQOL was significantly worse than U.S. normal values for six of eight domains of the SF-36. Several domains demonstrated moderate correlation (r value ≥ 0.40) with 6-minute-walk distance and World Health Organization functional class; there were no significant associations with hemodynamics. In univariable Cox proportional hazard models, six of eight domains and both summary scores were significantly associated with survival. In multivariable models, adjusted for age, disease type, and cardiac function, these relationships largely persisted.

Conclusions: In this cohort of patients with pulmonary arterial hypertension, HRQOL, as assessed by the SF-36, was strongly associated with transplant-free survival. These relationships persisted when controlling for potential confounders such as disease type and disease severity. These findings suggest that HRQOL may be an important predictor of outcomes in pulmonary arterial hypertension and therefore a target for future therapeutic interventions.

Keywords: outcomes; pulmonary hypertension; quality of life.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Spider plot of individual domain and summary scores in pulmonary arterial hypertension (PAH) versus U.S. population normative values. All values presented as means. *P < 0.05 for comparison with U.S. population norms. BP = body pain; GH = general health; MCS = mental component summary; MH = mental health; PCS = physical component summary; PF = physical functioning; RE = role emotional; RP = role physical; SF = social functioning; VT = vitality.
Figure 2.
Figure 2.
Survival stratified by Medical Outcomes Survey Short Form-36 survey (SF-36) physical component summary (PCS) score. High PCS = PCS greater than median score of cohort (median = 30.1 units); Low PCS = PCS less than median score of cohort.
See this image and copyright information in PMC

References

    1. Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar R, Landzberg M, Machado RF, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62:D34–D41. - PubMed
    1. Benza RL, Miller DP, Barst RJ, Badesch DB, Frost AE, McGoon MD. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry. Chest. 2012;142:448–456. - PubMed
    1. D’Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Kernis JT, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med. 1991;115:343–349. - PubMed
    1. Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS, Frost A, Barst RJ, Badesch DB, Elliott CG, et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) Circulation. 2010;122:164–172. - PubMed
    1. Thenappan T, Glassner C, Gomberg-Maitland M. Validation of the pulmonary hypertension connection equation for survival prediction in pulmonary arterial hypertension. Chest. 2012;141:642–650. - PubMed

Publication types

MeSH terms

LinkOut - more resources